Welcome to our dedicated page for Lemonade SEC filings (Ticker: LMND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lemonade, Inc. filings document operating results, governance, and capital-structure matters for its digital insurance business. Form 8-K reports furnish shareholder letters covering insurance operating metrics, financial condition, underwriting performance, profitability measures, and cash-flow disclosures.
The company's proxy materials address board and executive compensation matters, including equity-award and pay-versus-performance disclosures. Its SEC record also includes capital-structure and security-status filings related to warrants to purchase common stock, including exchange suspension, expiration, and Form 25 removal from listing and registration on NYSE American.
Lemonade (LMND) delivered Q2-25 top-line growth but remains unprofitable. Total revenue rose 34% YoY to $164.1 million, driven by a 26% increase in net earned premium (to $112.5 million) and higher ceding-commission income. Loss and LAE grew more slowly, improving the loss ratio to ~69% (vs. ~79% a year ago). Sales & marketing spend jumped 62% to $59.6 million as the company pursues expansion. Net loss narrowed to $43.9 million (-$0.60 per share) from $57.2 million (-$0.81), while weighted shares rose 3.8% to 73.4 million.
Operating cash outflow was $41.7 million for H1-25, in line with H1-24, and cash/equivalents held steady at $386 million. Borrowings under the General Catalyst marketing-finance facility increased to $123.5 million (from $83.4 million), boosting leverage but providing growth capital. Stock-based compensation fell to $25.7 million (H1-24: $30.3 million). Book value declined to $527.1 million as the accumulated deficit widened to $1.41 billion.
The reinsurance program was renewed on 1 Jul 25 with a sharply lower cession rate (~20% vs. ~55%), increasing Lemonade’s retained risk from Q3 onward. Q2 results include $16.9 million of California wildfire losses and a $6.9 million FAIR Plan assessment, partially offset by an $11.7 million Employee Retention Credit refund. Termination of the Chewy warrant agreement removed 3.17 million potential shares and reversed $5.2 million of previously accrued expense.
Lemonade, Inc. (LMND) – Form 4 filed 02-Jul-2025
Chief Financial Officer Timothy E. Bixby reported two same-day transactions dated 30-Jun-2025:
- Option exercise (Code “M”): 11,000 stock options exercised at an exercise price of $23.69.
- Open-market sale (Code “S”): the 11,000 resulting shares were sold at an average price of $42.69 under a Rule 10b5-1 plan adopted 12-Dec-2024.
After the transactions, Bixby’s direct ownership declined from 274,393 to 263,393 shares. He also holds 30,000 shares indirectly through the Timothy E. Bixby Family Trust, over which he has full voting and dispositive control. In addition, he retains 300,300 stock options outstanding after the exercise.
The option exercised was already fully vested and carries a 09-25-2029 expiration date. No other executives were included in this filing, and no operational or financial performance metrics were disclosed.
While insider sales can signal several motives (liquidity, diversification, tax), the modest size relative to Bixby’s remaining stake and the pre-arranged 10b5-1 plan suggest limited informational value for long-term shareholders.
Form 144 filing for Lemonade, Inc. (LMND) discloses a proposed sale of 11,000 common shares through Fidelity Brokerage Services on 06/30/2025. The shares carry an aggregate market value of $469,590, implying an indicative price of roughly $42.69 per share. Outstanding shares reported in the filing total 73,266,170, so the planned sale represents about 0.015 % of shares outstanding, a de-minimis ownership impact.
The form also summarizes insider activity over the preceding three months. Six transactions executed by Timothy E. Bixby between 06/03/2025 and 06/23/2025 amounted to 33,916 shares sold, yielding gross proceeds of ≈$1.394 million. Combining those sales with the new notice brings total disclosed dispositions to 44,916 shares since early June 2025.
While the filing does not list the seller’s formal relationship to the company, the repeated sales could signal ongoing personal liquidity moves or portfolio rebalancing. From a capital-structure perspective, the quantities are immaterial; however, continuing insider divestitures may weigh modestly on near-term investor sentiment.